Annual report
3750.TEDINET S100TUF6
Period2023-04-01 → 2024-03-31
Filed2024-06-26
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 147
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥1.6bn | 2023-04-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥2.1bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales |
| Revenue | ¥1.3bn | 2021-04-01 → 2022-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.4bn | 2020-04-01 → 2021-03-31d | Cons. | Net sales (5-year summary) |
| Revenue | ¥1.2bn | 2019-04-01 → 2020-03-31d | Cons. | Net sales (5-year summary) |
| Operating income | −¥773m | 2023-04-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | −¥794m | 2022-04-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | −¥907m | 2023-04-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥862m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income |
| Ordinary income | −¥418m | 2021-04-01 → 2022-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥746m | 2020-04-01 → 2021-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | −¥185m | 2019-04-01 → 2020-03-31d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥1.0bn | 2023-04-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | −¥1.2bn | 2022-04-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥138m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥78m | 2021-04-01 → 2022-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | −¥832m | 2020-04-01 → 2021-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥319m | 2019-04-01 → 2020-03-31d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥139m | 2023-04-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | −¥1.1bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥5.8bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥14.1bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥16.0bn | at 2022-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥14.9bn | at 2021-03-31d | Cons. | Total assets (5-year summary) |
| Total assets | ¥15.5bn | at 2020-03-31d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.0bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥11.4bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.8bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥2.7bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥3.7bn | at 2022-03-31d | Cons. | Net assets |
| Net assets / equity | ¥3.5bn | at 2021-03-31d | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥3.8bn | at 2020-03-31d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.0bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.1bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.0bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥673m | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥702m | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.1bn | at 2021-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥1000m | at 2020-03-31d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | −¥1.2bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥40m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | −¥188m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥83m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥532m | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | ¥8.7bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥283m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥216m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | ¥7m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥7.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥7.2bn | 2023-04-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥294m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥36m | 2021-04-01 → 2022-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥151m | 2020-04-01 → 2021-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6.4bn | 2019-04-01 → 2020-03-31d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥15.47 | 2023-04-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-118.71 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-8.79 | 2021-04-01 → 2022-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-101.64 | 2020-04-01 → 2021-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥47.58 | 2019-04-01 → 2020-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥15.42 | 2023-04-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥288.89 | at 2024-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥273.41 | at 2023-03-31 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥392.12 | at 2022-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥381.28 | at 2021-03-31d | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥568.06 | at 2020-03-31d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 44.3% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 17.3% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 21.9% | at 2022-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 22.3% | at 2021-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 24.6% | at 2020-03-31d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 5.5% | 2023-04-01 → 2024-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -35.6% | 2022-04-01 → 2023-03-31 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -2.3% | 2021-04-01 → 2022-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | -23.3% | 2020-04-01 → 2021-03-31d | Cons. | Rate of return on equity (5-year summary) |
| ROE | 8.6% | 2019-04-01 → 2020-03-31d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 16 | at 2024-03-31 | Cons. | Number of employees |
| Employees | 64 | at 2023-03-31 | Cons. | Number of employees |
| Employees | 63 | at 2022-03-31d | Cons. | Number of employees |
| Employees | 51 | at 2021-03-31d | Cons. | Number of employees |
| Employees | 53 | at 2020-03-31d | Cons. | Number of employees |
| Revenue | ¥638m | 2023-04-01 → 2024-03-31 | Standalone | Net sales |
| Revenue | ¥465m | 2022-04-01 → 2023-03-31 | Standalone | Net sales |
| Revenue | ¥153m | 2021-04-01 → 2022-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥142m | 2020-04-01 → 2021-03-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥235m | 2019-04-01 → 2020-03-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥450m | 2023-04-01 → 2024-03-31 | Standalone | Operating income |
| Operating income | −¥4m | 2022-04-01 → 2023-03-31 | Standalone | Operating income |
| Ordinary income | −¥587m | 2023-04-01 → 2024-03-31 | Standalone | Ordinary income |
| Ordinary income | −¥196m | 2022-04-01 → 2023-03-31 | Standalone | Ordinary income |
| Ordinary income | ¥212m | 2021-04-01 → 2022-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥93m | 2020-04-01 → 2021-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥451m | 2019-04-01 → 2020-03-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | −¥3.6bn | 2023-04-01 → 2024-03-31 | Standalone | Income before income taxes |
| Profit before tax | −¥814m | 2022-04-01 → 2023-03-31 | Standalone | Income before income taxes |
| Net income | −¥3.8bn | 2023-04-01 → 2024-03-31 | Standalone | Profit loss |
| Net income | −¥737m | 2022-04-01 → 2023-03-31 | Standalone | Profit loss |
| Net income | ¥270m | 2021-04-01 → 2022-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥8m | 2020-04-01 → 2021-03-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥544m | 2019-04-01 → 2020-03-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥3.3bn | at 2024-03-31 | Standalone | Assets |
| Total assets | ¥11.9bn | at 2023-03-31 | Standalone | Assets |
| Total assets | ¥13.0bn | at 2022-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥12.8bn | at 2021-03-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥9.8bn | at 2020-03-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥106m | at 2024-03-31 | Standalone | Liabilities |
| Total liabilities | ¥5.0bn | at 2023-03-31 | Standalone | Liabilities |
| Net assets / equity | ¥3.2bn | at 2024-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.0bn | at 2023-03-31 | Standalone | Net assets |
| Net assets / equity | ¥7.7bn | at 2022-03-31d | Standalone | Net assets |
| Net assets / equity | ¥7.2bn | at 2021-03-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥3.9bn | at 2020-03-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥534m | at 2024-03-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥466m | at 2023-03-31 | Standalone | Cash and deposits |
| EPS (basic) | ¥-421.48 | 2023-04-01 → 2024-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-82.54 | 2022-04-01 → 2023-03-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥30.61 | 2021-04-01 → 2022-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.97 | 2020-04-01 → 2021-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥81.01 | 2019-04-01 → 2020-03-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥30.39 | 2021-04-01 → 2022-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥0.96 | 2020-04-01 → 2021-03-31d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥10 | 2019-04-01 → 2020-03-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥357.21 | at 2024-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥778.7 | at 2023-03-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥861.25 | at 2022-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥823.29 | at 2021-03-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥587.5 | at 2020-03-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 90.4% | at 2024-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.5% | at 2023-03-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 57.7% | at 2022-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 54.5% | at 2021-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 40.2% | at 2020-03-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | -77.4% | 2023-04-01 → 2024-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | -10.4% | 2022-04-01 → 2023-03-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 3.8% | 2021-04-01 → 2022-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.2% | 2020-04-01 → 2021-03-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 14.5% | 2019-04-01 → 2020-03-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 8,929,419 | at 2024-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,929,419 | at 2023-03-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,929,419 | at 2022-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 8,711,419 | at 2021-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 7,183,195 | at 2020-03-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 2 | at 2024-03-31 | Standalone | Number of employees |
| Employees | 6 | at 2023-03-31 | Standalone | Number of employees |
| Employees | 5 | at 2022-03-31d | Standalone | Number of employees |
| Employees | 5 | at 2021-03-31d | Standalone | Number of employees |
| Employees | 5 | at 2020-03-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 43
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2023-04-01 → 2024-03-31 | ¥528,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2024-03-31 | ¥682m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2024-03-31 | −¥186m |
| Medical Asset Managemetreportable segment | capex | 2023-04-01 → 2024-03-31 | ¥3m |
| Medical Asset Managemetreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥15m |
| Medical Asset Managemetreportable segment | employees | at 2024-03-31 | 11 pure |
| Medical Asset Managemetreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥126m |
| Medical Asset Managemetreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥126m |
| Medical Asset Managemetreportable segment | segment assets | at 2024-03-31 | ¥373m |
| Medical Asset Managemetreportable segment | segment profit | 2023-04-01 → 2024-03-31 | −¥556m |
| Real Asset Managementreportable segment | depreciation | 2023-04-01 → 2024-03-31 | ¥193m |
| Real Asset Managementreportable segment | employees | at 2024-03-31 | 3 pure |
| Real Asset Managementreportable segment | revenue | 2023-04-01 → 2024-03-31 | ¥1.4bn |
| Real Asset Managementreportable segment | revenue external | 2023-04-01 → 2024-03-31 | ¥1.4bn |
| Real Asset Managementreportable segment | segment assets | at 2024-03-31 | ¥4.8bn |
| Real Asset Managementreportable segment | segment profit | 2023-04-01 → 2024-03-31 | −¥31m |
| —segment total | capex | 2023-04-01 → 2024-03-31 | ¥3m |
| —segment total | depreciation | 2023-04-01 → 2024-03-31 | ¥208m |
| —segment total | revenue | 2023-04-01 → 2024-03-31 | ¥1.6bn |
| —segment total | revenue external | 2023-04-01 → 2024-03-31 | ¥1.6bn |
| —segment total | segment assets | at 2024-03-31 | ¥5.1bn |
| —segment total | segment profit | 2023-04-01 → 2024-03-31 | −¥587m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2022-04-01 → 2023-03-31 | ¥625,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment assets | at 2023-03-31 | ¥635m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2023-03-31 | −¥161m |
| Medical Asset Managemetreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥54m |
| Medical Asset Managemetreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥15m |
| Medical Asset Managemetreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥238m |
| Medical Asset Managemetreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥238m |
| Medical Asset Managemetreportable segment | segment assets | at 2023-03-31 | ¥455m |
| Medical Asset Managemetreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥403m |
| Real Asset Managementreportable segment | capex | 2022-04-01 → 2023-03-31 | ¥110m |
| Real Asset Managementreportable segment | depreciation | 2022-04-01 → 2023-03-31 | ¥270m |
| Real Asset Managementreportable segment | revenue | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| Real Asset Managementreportable segment | revenue external | 2022-04-01 → 2023-03-31 | ¥1.9bn |
| Real Asset Managementreportable segment | segment assets | at 2023-03-31 | ¥13.0bn |
| Real Asset Managementreportable segment | segment profit | 2022-04-01 → 2023-03-31 | −¥230m |
| —segment total | capex | 2022-04-01 → 2023-03-31 | ¥164m |
| —segment total | depreciation | 2022-04-01 → 2023-03-31 | ¥285m |
| —segment total | revenue | 2022-04-01 → 2023-03-31 | ¥2.1bn |
| —segment total | revenue external | 2022-04-01 → 2023-03-31 | ¥2.1bn |
| —segment total | segment assets | at 2023-03-31 | ¥13.5bn |
| —segment total | segment profit | 2022-04-01 → 2023-03-31 | −¥633m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,236
| Item | Context | Value | Unit |
|---|---|---|---|
| Net cash provided by used in investing activities (5-year summary) | CurrentYearDuration | 8689978000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior4YearDuration | 6358358000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior3YearDuration | 150647000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior2YearDuration | 35797000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | 294227000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | CurrentYearDuration | -7172572000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior4YearInstant | 999505000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior3YearInstant | 1069738000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior2YearInstant | 701558000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 673050000 | JPY |
| Cash and cash equivalents (5-year summary) | CurrentYearInstant | 1038227000 | JPY |
| Number of employees | Prior4YearInstant | 53 | |
| Number of employees | Prior3YearInstant | 51 | |
| Number of employees | Prior2YearInstant | 63 | |
| Number of employees | Prior1YearInstant | 64 | |
| Number of employees | CurrentYearInstant | 16 | |
| Average number of temporary workers | Prior4YearInstant | 34 | |
| Average number of temporary workers | Prior3YearInstant | 41 | |
| Average number of temporary workers | Prior2YearInstant | 52 | |
| Average number of temporary workers | Prior1YearInstant | 55 | |
| Average number of temporary workers | CurrentYearInstant | 20 | |
| Net sales (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 235364000 | JPY |
| Net sales (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 142339000 | JPY |
| Net sales (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 153010000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration_NonConsolidatedMember | 464903000 | JPY |
| Net sales (5-year summary) | CurrentYearDuration_NonConsolidatedMember | 637567000 | JPY |
| Ordinary income loss (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 450920000 | JPY |
| Ordinary income loss (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 92602000 | JPY |
| Ordinary income loss (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 212071000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -195532000 | JPY |
| Ordinary income loss (5-year summary) | CurrentYearDuration_NonConsolidatedMember | -587198000 | JPY |
| Net income loss (5-year summary) | Prior4YearDuration_NonConsolidatedMember | 543770000 | JPY |
| Net income loss (5-year summary) | Prior3YearDuration_NonConsolidatedMember | 7962000 | JPY |
| Net income loss (5-year summary) | Prior2YearDuration_NonConsolidatedMember | 270316000 | JPY |
| Net income loss (5-year summary) | Prior1YearDuration_NonConsolidatedMember | -736992000 | JPY |
| Net income loss (5-year summary) | CurrentYearDuration_NonConsolidatedMember | -3763141000 | JPY |
| Capital stock (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 100000000 | JPY |
| Capital stock (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 100000000 | JPY |
| Capital stock (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 100000000 | JPY |
| Capital stock (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 100000000 | JPY |
| Capital stock (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 100000000 | JPY |
| Total number of issued shares (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 7183195 | |
| Total number of issued shares (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 8711419 | |
| Total number of issued shares (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 8929419 | |
| Total number of issued shares (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 8929419 | |
| Total number of issued shares (5-year summary) | CurrentYearInstant_NonConsolidatedMember | 8929419 | |
| Net assets (5-year summary) | Prior4YearInstant_NonConsolidatedMember | 3943267000 | JPY |
| Net assets (5-year summary) | Prior3YearInstant_NonConsolidatedMember | 7171668000 | JPY |
| Net assets (5-year summary) | Prior2YearInstant_NonConsolidatedMember | 7689900000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant_NonConsolidatedMember | 6952650000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |